Abstract
Uncontrolled systemic inflammatory immune triggering has hampered the clinical translation of several classes of small-molecule immunomodulators, such as imidazoquinoline TLR7/8 agonists for vaccine design and cancer immunotherapy. By taking advantage of the inherent serum-protein-binding property of lipid motifs and their tendency to accumulate in lymphoid tissue, we designed amphiphilic lipid–polymer conjugates that suppress systemic inflammation but provoke potent lymph-node immune activation. This work provides a rational basis for the design of lipid–polymer amphiphiles for optimized lymphoid targeting.
Original language | English |
---|---|
Journal | Angewandte Chemie - International Edition |
Volume | 58 |
Issue | 43 |
Pages (from-to) | 15390-15395 |
Number of pages | 6 |
ISSN | 1433-7851 |
DOIs | |
Publication status | Published - Oct 2019 |
Keywords
- immunomodulation
- innate immunity
- lipid amphiphiles
- lymph nodes
- polymers